Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Biogen Forges $278M MS Tie-Up With Alkermes

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

Biogen will receive an exclusive, worldwide license to commercialize ALKS 8700 and will pay Alkermes a mid-teens royalty on worldwide net sales of ALKS 8700. Source: BioSpace

Continue ReadingBiogen Forges $278M MS Tie-Up With Alkermes

Bay Area's Medeor Therapeutics Bags $57M

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

The financing will be used to push its Phase III clinical program of MDR-101 in living donor HLA-matched kidney transplant patients. Source: BioSpace

Continue ReadingBay Area's Medeor Therapeutics Bags $57M

AmerisourceBergen Coughs Up $625M to Resolve U.S. Government Probe

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:BioPharma

The agreement, whose final terms are still being negotiated, must be approved by a court. Source: BioSpace

Continue ReadingAmerisourceBergen Coughs Up $625M to Resolve U.S. Government Probe

Eli Lilly Quietly Works on Wearable Devices in Lab Established in 2015

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:BioPharma

Eli Lilly continues to make investments in its diabetes business. Source: BioSpace

Continue ReadingEli Lilly Quietly Works on Wearable Devices in Lab Established in 2015

Pfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:BioPharma

Genentech is claiming that Pfizer's proposed biosimilar infringes 40 of its patents. Source: BioSpace

Continue ReadingPfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents

Massachusetts Upstart Takes on Mighty Purdue Pharma Over Tougher-to-Abuse Opioids

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:BioPharma

A number of biopharma companies are making strides in developing non-opioid pain killers or opioids that are more difficult to abuse. Source: BioSpace

Continue ReadingMassachusetts Upstart Takes on Mighty Purdue Pharma Over Tougher-to-Abuse Opioids

The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:BioPharma

Keith Speights, writing for The Motley Fool, notes one biotech that's booming. Source: BioSpace

Continue ReadingThe Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More

Canada's Concordia Accused of 6,000% Price Increase for Drug, Overcharging NHS by 100M Pounds

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:BioPharma

The price of a single pill went up from 16p to 9.22 pounds, even though production costs remained broadly stable during that period, the CMA said. Source: BioSpace

Continue ReadingCanada's Concordia Accused of 6,000% Price Increase for Drug, Overcharging NHS by 100M Pounds

GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:BioPharma

HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace

Continue ReadingGlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen

This is What Amazon Can Do to Start Selling Drugs Faster

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:BioPharma

Both Amazon and Rite Aid offered no comment for this story. Source: BioSpace

Continue ReadingThis is What Amazon Can Do to Start Selling Drugs Faster
  • Go to the previous page
  • 1
  • …
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.